Model system for phenotypic characterization of sequence variations in the LDL receptor gene

Clinical Chemistry

Volumn 52, Issue 8, 2006, Pages 1469-1479

  Ranheim, Trine ^a   Kulseth, Mari Ann ^a   Berge, Knut Erik ^a   Leren, Trond Paul ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CHO CELL; COATED PIT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; FAMILIAL HYPERCHOLESTEROLEMIA; FLOW CYTOMETRY; GENETIC VARIABILITY; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTERNALIZATION; MISSENSE MUTATION; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; HUMANS; IODINE RADIOISOTOPES; LIPOPROTEINS, LDL; MICROSCOPY, CONFOCAL; MUTATION; RECEPTORS, LDL; VARIATION (GENETICS);

EID: 33746584774     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.068627     Document Type: Article

References (35)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 2001:2863-913.
2. Division of Cardiovascular Genetics. Department of Medicine, University College London Medical School. The low density lipoprotein receptor (LDLR) gene in familial hypercholesterolemia. http://www.ucl.ac.uk/fh (accessed).
3. Laboratory of Human Genetics. Universal mutation database (UMD). http://www.umd.necker.fr (accessed)
4. Tolleshaug H, Goldstein JL, Schneider WJ, Brown MS. Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell 1982;30:715-24.
5. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
6. Davis CG, Lehrman MA, Russell DW, Anderson RG, Brown MS, Goldstein JL. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell 1986;45:15-24.
7. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1:445-66.
8. Bertolini S, Pisciotta L, Di SL, Langheim S, Bellocchio A, Masturzo P, et al. Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 2004;174: 57-65.
9. Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 1990;24:133-70.
10. Hobbs HH, Leitersdorf E, Goldstein JL, Brown MS, Russell DW. Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions. J Clin Invest 1988;81:909-17.
11. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985;1:1-39.
12. Lehrman MA, Goldstein JL, Brown MS, Russell DW, Schneider WJ. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 1985;41:735-43.
13. Beglova N, Jeon H, Fisher C, Blacklow SC. Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor. Mol Cell 2004;16:281-92.
14. Sorensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA. Retention of mutant low density lipoprotein receptor in ER leads to ER stress. J Biol Chem 2006;281:468-76.
15. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A 1984;81:1991-5.
16. Peacock SL, Bates MP, Russell DW, Brown MS, Goldstein JL. Human low density lipoprotein receptor expressed in Xenopus oocytes. Conserved signals for 0-linked glycosylation and receptor-mediated endocytosis. J Biol Chem 1988;263:7838-45.
17. Beisiegel U, Schneider WJ, Goldstein JL, Anderson RG, Brown MS. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem 1981;256: 11923-31.
18. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
19. Pitas RE, Innerarity TL, Weinstein JN, Mahley RW. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1981;1:177-85.
20. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CA Jr, Attie AD. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 1983;212: 791-800.
21. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 1983;98:241-60.
22. Gillian-Daniel DL, Bates PW, Tebon A, Attie AD. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A 2002;99:4337-42.
23. Mu FT, Callaghan JM, Steele-Mortimer O, Stenmark H, Parton RG, Campbell PL, et al. EEA1, an early endosome-associated protein. EEA1 is a conserved α-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J Biol Chem 1995;270:13503-11.
24. Goldstein JL, Brown MS, Stone NJ. Genetics of the LDL receptor: evidence that the mutations affecting binding and internalization are allelic. Cell 1977;12:629-41.
25. Robinson MS. The role of clathrin, adaptors and dynamin in endocytosis. Curr Opin Cell Biol 1994;6:538-44.
26. Stephan ZF, Yurachek EC. Rapid fluorometric assay of LDL receptor activity by Dil-labeled LDL. J Lipid Res 1993;34:325-30.
27. Schmitz G, Bruning T, Kovacs E, Barlage S. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscler Thromb 1993;13:1053-65.
28. Esser V, Russell DW. Transport-deficient mutations in the low density lipoprotein receptor. Alterations in the cysteine-rich and cysteine-poor regions of the protein block intracellular transport. J Biol Chem 1988;263:13276-81.
29. Russell DW, Brown MS, Goldstein JL. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 1989;264: 21682-8.
30. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A 2003;100: 928-33.
31. Park SW, Moon YA, Norton JD. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem 2004;279: 50630-8.
32. Davis CG, Goldstein JL, Sudhof TC, Anderson RG, Russell DW, Brown MS. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature 1987;326:760-5.
33. Goldstein JL, Anderson RG, Brown MS. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979;279: 679-85.
34. Chang JH, Pan JP, Tai DY, Huang AC, Li PH, Ho HL, et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. J Lipid Res 2003;44:1850-8.
35. Jensen TG, Andresen BS, Jensen HK, Jensen LG, Heath F, Pedersen S, et al. Rapid characterization of disease-causing mutations in the low density lipoprotein receptor (LDL-R) gene by overexpression in COS cells. Z Gastroenterol 1996;34(Suppl 3):9-11.